Quick Hits: Imodium Abuse, Polypharmacy and Hospitalization & More

Quick Hits: Transvaginal Mesh Pulled, New Weight Loss Drug & More

The FDA is requesting that the over-the-counter anti-diarrhea medicine Imodium (loperamide) be packaged differently to prevent abuse. There have been numerous reports indicating that people have intentionally misused and abused high doses of the treatment as a substitute for opioid drugs. In some cases, this has led to serious heart problems and death. In order to rectify this problem, the agency sent a letter to manufacturers asking that they limit the amount of drug per package for short-term use. For instance, a package could contain 8 2-milligram capsules, which would be enough for about 2 days. Posted January 30, 2018. Via FDA.

Taking 5 or more drugs increases hospitalization risk among older adults both with and without HIV. Yale researchers collected data from the Veterans Aging Cohort Study and analyzed adults with and without HIV who received at least 1 medication in 2009. The research team analyzed the patients, who were around 50 years old, over the course of 6 years. The results of the study indicated that older people — both with and without HIV — who took multiple drugs simultaneously had a greater risk of being hospitalized or dying. Posted January 30, 2018. Via AIDS.

The boxed warning on 2 classes of asthma medications has been removed. The warning on long-acting beta-agonists (LABAs) and inhaled corticosteroids (ICS) that cautioned consumers about asthma-related death was removed after the FDA reviewed 4 large clinical trials and found that treating asthma with LABAs in combination with ICS does not cause more serious asthma-related side effects (such as hospitalization, the need for a breathing tube, or asthma-related deaths) than treatment with ICS alone. Posted December 20, 2017. Via FDA.


Alanna McCatty

Alanna McCatty

Alanna McCatty is founder and CEO of McCatty Scholars, an organization that devises and implements financial literacy programs for students to combat the nationwide issue of the loss of educational opportunity due to the ramifications of burdensome student debt. At MedShadow, she reports on new findings and research on the side effects of prescription drugs. She is a graduate of Pace University.


Did you find this article helpful?


Latest News

Breaking News – EpiPen Malfunction

Breaking News – EpiPen Malfunction

Just released from the FDA – Pfizer has informed the FDA that they are aware of several continuing problems that people are having using the EpiPen (epinephrine) and EpiPen Jr (epinephrine) auto-injectors and generic versions. Some of the problems are from user error and some from EpiPen malfunction. Here are…

ACE Inhibitors in the Time of Coronavirus

ACE Inhibitors in the Time of Coronavirus

Are you worried about ACE inhibitors and coronavirus? You may be hearing that one of the entry methods for the coronavirus in humans is by attaching to the ACE-2 enzyme. This has raised alarms among those with heart disease who use ACE inhibitors (with names ending in -pril, such as…

  • Advertisement